SLS
SELLAS Life Sciences Group, Inc.
NASDAQ · Healthcare · Biotechnology · US
$11.49
−0.35%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$0.05
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 11, 2026
- EPS actual
- -$0.05
- EPS estimate
- -$0.04
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +8.0%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 11, 2026 | -$0.04 | -$0.05 | Miss -11.11% | — |
| May 12, 2026 | -$0.06 | -$0.05 | Beat 16.67% | — |
| Mar 19, 2026 | -$0.06 | -$0.05 | Beat 21.05% | — |
| Nov 12, 2025 | -$0.06 | -$0.06 | Beat 5.26% | — |
| Aug 12, 2025 | -$0.08 | -$0.07 | Beat 16.00% | — |
| Mar 20, 2025 | -$0.11 | -$0.08 | Beat 27.27% | — |
| Aug 13, 2024 | -$0.16 | -$0.13 | Beat 18.75% | — |
| Nov 9, 2023 | -$0.03 | -$0.33 | Miss -1200.24% | — |
| Aug 10, 2023 | -$0.35 | -$0.31 | Beat 11.43% | — |
| May 11, 2023 | -$0.29 | -$0.47 | Miss -62.07% | — |
| Mar 16, 2023 | $0.32 | -$0.43 | Miss -234.38% | $1.0M |
| Nov 14, 2022 | -$0.39 | -$0.34 | Beat 12.82% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026